MiNK Therapeutics Dr. Jennifer Buell to Deliver Featured Plenary at 10th Annual CAR-TCR Summit in Boston, MA

Benzinga
2025.09.25 12:37
portai
I'm PortAI, I can summarize articles.

紐約，2025 年 9 月 25 日（GLOBE NEWSWIRE）-- MiNK Therapeutics, Inc.（納斯達克：INKT），一家在臨牀階段的生物製藥公司，開創了不變自然殺傷 T 細胞（iNKT）療法，今天宣佈其總裁兼首席執行官 Jennifer Buell 博士將發表

Source: Benzinga The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.